S. Rosen

Oncology · Blood · 2007–2022

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom S. Rosen trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Bruce H. Thiers (in Aerospace Engineering)

Papers from S. Rosen's perspective

Ordered by how strongly the researchers S. Rosen trusts endorse each paper. Same corpus, a different order for every researcher.

  1. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. (Blood)
  2. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. (Journal of Clinical Oncology)
  3. Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
  4. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. (Cancer Research)
  5. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination… (Journal of Clinical Oncology)
  6. The BATTLE Trial: Personalizing Therapy for Lung Cancer (Cancer Discovery)
  7. Revised response criteria for malignant lymphoma. (Journal of Clinical Oncology)
  8. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors (Journal of Nuclear Medicine)
  9. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. (New England Journal of Medicine)
  10. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 (European Journal of Nuclear Medicine and Molecular Imaging)

Their papers